Adverum Biotechnologies earnings were -$130.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ADVM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$60.5M, up 123.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADVM reported annual earnings of -$130.9M, with 7.2% growth. The next ADVM earnings date is May 7, 2025.
Adverum Biotechnologies Earnings Reports & History FAQ
What were Adverum Biotechnologies's earnings last quarter?
On ADVM's earnings call on Invalid Date, Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 2024 earnings per share (EPS) of -$2.99, up 5.65% year over year. Total ADVM earnings for the quarter were -$60.53 million. In the same quarter last year, Adverum Biotechnologies's earnings per share (EPS) was -$2.83.
When does Adverum Biotechnologies report earnings?
The next ADVM earnings date is Invalid Date. Add ADVM to your watchlist to be reminded of Adverum Biotechnologies's next earnings date.
What was ADVM's earnings growth in the past year?
As of Adverum Biotechnologies's earnings date in Invalid Date, Adverum Biotechnologies's earnings has grown year over year. ADVM earnings in the past year totalled -$130.93 million.
Is Adverum Biotechnologies profitable or losing money?
As of the last Adverum Biotechnologies earnings report, Adverum Biotechnologies is currently losing money. Adverum Biotechnologies's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$130.93 million, a 7.22% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.